AAAAAA

   
Results: 1-2 |
Results: 2
THE USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR INCOMBINATION WITH SINGLE OR FRACTIONATED DOSES OF IFOSFAMIDE AND DOXORUBICIN IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
Authors: ERKISI M ERKURT E OZBARLAS S BURGUT R DORAN F SEYREK E
Citation: M. Erkisi et al., THE USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR INCOMBINATION WITH SINGLE OR FRACTIONATED DOSES OF IFOSFAMIDE AND DOXORUBICIN IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, Journal of chemotherapy, 8(3), 1996, pp. 224-228
THE USE OF R-MET HU 6-CSF IN COMBINATION WITH HIGH AND STANDARD DOSESOF IFOSFAMIDE AND DOXORUBICIN IN THE PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
Authors: ERKISI M ERKURT E OZBARLAS S BURGUT R DORAN F SEYREK E
Citation: M. Erkisi et al., THE USE OF R-MET HU 6-CSF IN COMBINATION WITH HIGH AND STANDARD DOSESOF IFOSFAMIDE AND DOXORUBICIN IN THE PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, European journal of cancer, 31A, 1995, pp. 855-855
Risultati: 1-2 |